1. A human brain microphysiological iPSC-derived system to study neurotoxicity. (10th October 2018) Authors: Hogberg, H.T.; Barreras, P.; Chesnut, M.; Gama, L.; Harris, G.; Pardo, C.A.; Smirnova, L.; Zhong, X.; Hartung, T.; Pamies, D. Journal: Toxicology letters Issue: Volume 295(2018)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brain Organoids to Study SARS-Cov-2 Infection of Developing CNS. (September 2021) Authors: Smirnova, L.; Bullen, C.K.; Hogberg, H.T.; Pekosz, A.; Bishai, W; Hartung, T. Journal: Toxicology letters Issue: Volume 350(2021)Supplement Page Start: S69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cellular resilience in neurotoxicity: The case of Parkinson's disease. (16th September 2016) Authors: Smirnova, L.; Harris, G.; Zhao, L.; Maertens, A.; Hartung, T. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DNA-hydrolyzing catalytic IgGs from schizophrenia patients do not affect cell viability of the SH-SY5Y human neuroblastoma cell line. (1st June 2022) Authors: Epimakhova, E.; Ermakov, E.; Kazantseva, D.; Parshukova, D.; Dmitrieva, E.; Smirnova, L.; Ivanova, S.; Semke, A. Journal: European psychiatry Issue: Volume 65:Supplement 1(2022) Page Start: S775 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Gene-Environmental Interactions in Autism with iPSC-derived brain organoids: microRNA and Metabolic Biomarkers of the Synergy. (September 2021) Authors: Modaferi, S.; Zhong, X.; Fagiani, F.; Kleensang, A.; Murata, Y.; Hartung, T; Smirnova, L. Journal: Toxicology letters Issue: Volume 350(2021)Supplement Page Start: S141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Human 3D brain model to study developmental neurotoxicity. (September 2021) Authors: Pamies, D.; Chestnut, M.; Hartung, T.; Smirnova, L.; Zurich, M.-G.; Hogberg, H. Journal: Toxicology letters Issue: Volume 350(2021)Supplement Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. IPSC derived brain microphysiological system for developmental neurotoxicity. (10th October 2016) Authors: Pamies, D.; Barreras, P.; Block, K.; Makri, G.; Kumar, A.; Wiersma, D.; Smirnova, L.; Zang, C.; Bressler, J.; Christian, K.M.; Harris, G.; Berlinicke, C.J.; Kyro, K.; Song, H.; Pardo, C.A.; Hartung, T.; Hogberg, H.T. Journal: Toxicology letters Issue: Volume 259(2016)Supplement Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Marker of schizophrenia with enduring negative symptoms. (1st June 2022) Authors: Dmitrieva, E.; Smirnova, L.; Semke, A. Journal: European psychiatry Issue: Volume 65:Supplement 1(2022) Page Start: S775 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Mechanisms of toxicity and resilience of an in vitro 3D human dopaminergic model to Rotenone. (10th October 2016) Authors: Harris, G.; Maertens, A.; Pamies, D.; Hogberg, H.; Delp, J.; Hartung, T.; Smirnova, L. Journal: Toxicology letters Issue: Volume 259(2016)Supplement Page Start: S204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Superoxide dismutase activity of serum IgG in acute illness and remission period of schizophrenia. (1st June 2022) Authors: Mednova, I.; Smirnova, L.; Vasilieva, A.; Krotenko, N.; Dmitrieva, E.; Semke, A.; Ivanova, S. Journal: European psychiatry Issue: Volume 65:Supplement 1(2022) Page Start: S286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗